CancerRadarCancerRadar
Electromagnetic therapyFDA-approvedInvestigational

Tumor Treating Fields (TTF) with Optune

How it works

Delivers low-intensity, alternating electric fields that disrupt cancer cell division and induce cell death.

Cancer types

Colorectal Cancer

Efficacy

Studies show that TTF with Optune can improve survival and response rates in patients with recurrent glioblastoma, with approximately 20% of patients achieving a complete response.

Side effects

Mild

Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.

This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.